Cargando…
Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study
The objective of this study was to determine the conversion rate of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER) and progesterone receptor (PR) between primary tumors and metastatic lesions in advanced breast cancer. Patients with suspected diagnosis of locally recurrent o...
Autores principales: | de Dueñas, Eduardo Martínez, Hernández, Ana Lluch, Zotano, Ángel Guerrero, Carrión, Ramón María Pérez, López-Muñiz, José Ignacio Chacón, Novoa, Silvia Antolín, Rodríguez, Ángela López, Fidalgo, José Alejandro Pérez, Lozano, Jaime Ferrer, Gasión, Octavio Burgués, Carrascal, Eva Carrasco, Capilla, Andrés Hernando, López-Barajas, Isabel Blancas, Mateu, Montserrat Muñoz, de Ceballos Reyna, María Helena López, Ferrando, Amparo Oltra, Jañez, Noelia Martínez, Ballerini, Vicente Carañana, Torres, Antonio Antón, Catalán, Gustavo, Sáenz, José Ángel García, Menjón, Salomón, González-Angulo, Ana María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907670/ https://www.ncbi.nlm.nih.gov/pubmed/24414130 http://dx.doi.org/10.1007/s10549-013-2825-2 |
Ejemplares similares
-
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID‐19 Pandemic in Spain
por: Martin, Miguel, et al.
Publicado: (2020) -
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study
por: Fernández de Larrea-Baz, Nerea, et al.
Publicado: (2020) -
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)
por: Lopez-Tarruella, Sara, et al.
Publicado: (2019) -
SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
por: Garcia-Saenz, Jose Angel, et al.
Publicado: (2023) -
Correction to: SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
por: Garcia-Saenz, Jose Angel, et al.
Publicado: (2023)